RICE HALL JAMES & ASSOCIATES, LLC - EAGLE PHARMACEUTICALS INC ownership

EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 148 filers reported holding EAGLE PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 0.35 and the average weighting 0.9%.

Quarter-by-quarter ownership
RICE HALL JAMES & ASSOCIATES, LLC ownership history of EAGLE PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2018$912,000
-35.9%
22,628
+10.2%
0.03%
-35.3%
Q3 2018$1,423,000
-47.0%
20,527
-42.1%
0.05%
-48.0%
Q2 2018$2,683,000
+142.4%
35,459
+68.8%
0.10%
+127.9%
Q1 2018$1,107,000
-93.0%
21,007
-89.6%
0.04%
-93.8%
Q2 2017$15,928,000
+46.9%
201,904
+54.5%
0.69%
+31.2%
Q1 2017$10,842,000130,7190.53%
Other shareholders
EAGLE PHARMACEUTICALS INC shareholders Q1 2017
NameSharesValueWeighting ↓
Park West Asset Management LLC 1,120,235$53,749,0002.66%
TANG CAPITAL MANAGEMENT LLC 255,616$12,264,0001.19%
Smith, Graham & Co., Investment Advisors, LP 158,671$7,613,0000.92%
ARMISTICE CAPITAL, LLC 282,000$13,530,0000.59%
Capital Impact Advisors, LLC 35,815$1,718,0000.57%
Matarin Capital Management, LLC 58,977$2,830,0000.56%
GLOBEFLEX CAPITAL L P 31,702$1,521,0000.39%
CHARTWELL INVESTMENT PARTNERS, LLC 200,246$9,608,0000.37%
Stanley-Laman Group, Ltd. 24,000$1,152,0000.28%
VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. 264$13,0000.20%
View complete list of EAGLE PHARMACEUTICALS INC shareholders